Johnson & Johnson (JNJ) Current Assets (2009 - 2026)
Johnson & Johnson recorded quarterly Current Assets of $59.2 billion in Q1 2026, up 6.38% quarter-over-quarter from $55.6 billion in Q4 2025, and down 17.3% year-over-year from $71.6 billion in Q1 2025.
Johnson & Johnson's Current Assets history runs 18 years deep, the most recent figure standing at $59.2 billion for Q1 2026.
- In Q1 2026, Current Assets fell 17.3% year-over-year to $59.2 billion; the TTM figure through Mar 2026 stood at $59.2 billion (down 17.3% YoY), while the FY2025 annual figure was $55.6 billion, changed 0.48% from the prior year.
- Current Assets came in at $59.2 billion for Q1 2026 at Johnson & Johnson, up from $55.6 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $71.6 billion in Q1 2025 to a low of $53.2 billion in Q3 2024.
- A 5-year average of $58.7 billion and a median of $57.4 billion in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets declined 17.68% in 2023 and advanced 25.52% in 2025, its largest moves.
- Johnson & Johnson's Current Assets stood at $65.2 billion in 2022, then retreated by 18.0% to $53.5 billion in 2023, then rose by 4.48% to $55.9 billion in 2024, then retreated by 0.48% to $55.6 billion in 2025, then increased by 6.38% to $59.2 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $59.2 billion, $55.6 billion, and $54.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 54.84 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 59.17 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 27.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 23.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 59.17 Bn |
| Dec 28, 2025 | 55.62 Bn |
| Sep 28, 2025 | 54.61 Bn |
| Jun 29, 2025 | 54.50 Bn |
| Mar 30, 2025 | 71.55 Bn |
| Dec 29, 2024 | 55.89 Bn |
| Sep 29, 2024 | 53.25 Bn |
| Jun 30, 2024 | 57.82 Bn |
| Mar 31, 2024 | 57.00 Bn |
| Dec 31, 2023 | 53.50 Bn |
| Oct 1, 2023 | 53.70 Bn |
| Jul 2, 2023 | 60.57 Bn |
| Apr 2, 2023 | 64.39 Bn |
| Jan 1, 2023 | 55.29 Bn |
| Oct 2, 2022 | 65.24 Bn |
| Jul 3, 2022 | 63.85 Bn |
| Apr 3, 2022 | 60.42 Bn |
| Jan 2, 2022 | 60.98 Bn |
| Oct 3, 2021 | 59.89 Bn |
| Jul 4, 2021 | 53.77 Bn |
| Apr 4, 2021 | 52.53 Bn |
| Jan 3, 2021 | 51.24 Bn |
| Sep 27, 2020 | 57.58 Bn |
| Jun 28, 2020 | 45.89 Bn |
| Mar 29, 2020 | 44.23 Bn |
| Dec 29, 2019 | 45.27 Bn |
| Sep 29, 2019 | 44.33 Bn |
| Jun 30, 2019 | 41.80 Bn |
| Mar 31, 2019 | 41.99 Bn |
| Dec 30, 2018 | 46.03 Bn |
| Sep 30, 2018 | 47.19 Bn |
| Jul 1, 2018 | 45.44 Bn |
| Apr 1, 2018 | 42.77 Bn |
| Dec 31, 2017 | 43.09 Bn |
| Oct 1, 2017 | 41.83 Bn |
| Jul 2, 2017 | 38.79 Bn |
| Apr 2, 2017 | 63.35 Bn |
| Jan 1, 2017 | 65.03 Bn |
| Oct 2, 2016 | 63.32 Bn |
| Jul 3, 2016 | 66.29 Bn |
| Apr 3, 2016 | 62.74 Bn |
| Jan 3, 2016 | 60.21 Bn |
| Sep 27, 2015 | 63.49 Bn |
| Jun 28, 2015 | 61.00 Bn |
| Mar 29, 2015 | 58.19 Bn |
| Dec 28, 2014 | 55.74 Bn |
| Sep 28, 2014 | 59.97 Bn |
| Jun 29, 2014 | 60.12 Bn |
| Mar 30, 2014 | 57.37 Bn |
| Dec 29, 2013 | 56.41 Bn |
| Sep 29, 2013 | 52.18 Bn |
| Jun 30, 2013 | 51.27 Bn |
| Mar 31, 2013 | 47.23 Bn |
| Dec 30, 2012 | 46.12 Bn |
| Sep 30, 2012 | 44.79 Bn |
| Jul 1, 2012 | 41.62 Bn |
| Apr 1, 2012 | 57.01 Bn |
| Jan 1, 2012 | 54.32 Bn |
| Oct 2, 2011 | 53.44 Bn |
| Jul 3, 2011 | 52.67 Bn |
| Apr 3, 2011 | 49.22 Bn |
| Jan 2, 2011 | 47.31 Bn |
| Oct 3, 2010 | 42.72 Bn |
| Jul 4, 2010 | 39.02 Bn |
| Apr 4, 2010 | 38.86 Bn |
| Jan 3, 2010 | 39.54 Bn |
| Sep 27, 2009 | 35.60 Bn |
| Jun 28, 2009 | 35.49 Bn |